Identification of an Extracellular Signal-regulated Kinase (ERK) Docking Site in Ribosomal S6 Kinase, a Sequence Critical for Activation by ERK in Vivo
Open accessAbstract
Glutathione S-transferase (GST)-fusion proteins containing the carboxyl-terminal tails of three p90 ribosomal S6 kinase (RSK) isozymes (RSK1, RSK2, and RSK3) interacted with extracellular signal-regulated kinase (ERK) but not c-Jun-NH2-kinase (JNK) or p38 mitogen-activated protein kinase (MAPK). Within the carboxyl-terminal residues of the RSK isozymes is a region of high conservation corresponding to residues 722LAQRRVRKLPSTTL735 in RSK1. Truncation of the carboxyl-terminal 9 residues, 727VRKLPSTTL735, completely eliminated the interaction of the GST-RSK1 fusion protein with purified recombinant ERK2, whereas the truncation of residues 731PSTTL735 had no effect on the interaction with purified ERK2. ERK1 and ERK2 co-immunoprecipitated with hemagglutinin-tagged wild type RSK2 (HA-RSK2) in BHK cell cytosol. However, ERK did not co-immunoprecipitate with HA-RSK2((1-729)), a mutant missing the carboxyl-terminal 11 amino acids, similar to the minimal truncation that eliminated in vitro interaction of ERK with the GST-RSK1 fusion protein. Kinase activity of HA-RSK2 increased 6-fold in response to insulin. HA-RSK2((1-729)) had a similar basal kinase activity to that of HA-RSK2 but was not affected by insulin treatment. Immunoprecipitated HA-RSK2 and HA-RSK2((1-729)) could be activated to the same extent in vitro by active ERK2, demonstrating that HA-RSK2((1-729)) was properly folded. These data suggest that the conserved region of the RSK isozymes (722LAQRRVRKL730 of RSK1) provides for a specific ERK docking site approximately 150 amino acids carboxyl-terminal to the nearest identified ERK phosphorylation site (Thr573). Complex formation between RSK and ERK is essential for the activation of RSK by ERK in vivo. Comparison of the docking site of RSK with the carboxyl-terminal tails of other MAPK-activated kinases reveals putative docking sites within each of these MAPK-targeted kinases. The number and placement of lysine and arginine residues within the conserved region correlate with specificity for activation by ERK and p38 MAPKs in vivo.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MAPK scaffolding proteins JIP1 and PEA-15 and substrates RSK1, MK2, and MEF2a also contain a linear KIM domain that mediates MAPK binding in the cell.
“Notably, MAPK scaffolding proteins (JNK-interacting protein, JIP1; 29 phosphoprotein enriched in astrocytes 15, PEA-15 30 ) and substrates (Ribosomal protein S6 kinase alpha-1, RSK1; 31 MAP kinase-activated protein kinase 2, MK2; 32 and myocyte enhancer factor 2A, MEF2a 33 ) also contain linear KIM domain, which mediates MAPK binding in the cell.”
From Molecular basis of MAP kinase regulation (2013) · cites this paper as [31]
The citation lists haven’t been fetched yet
References 36 · Cited by 283
- Authors
- Smith, J. A., Poteet-Smith, C. E., Malarkey, K., & Sturgill, T. W.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Sturgill, Thomas W.
- ORCID
- Smith, Jeffrey A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 274
- Issue
- 5
- Pages
- 2893-2898
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2018221682
- Cited by
- 283
- References
- 36
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 6
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK41077, R01DK041077)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- RSK, ERK2, RSK1, RSK2, carboxyl-terminal tail, protein-protein interaction, MAPK signaling, insulin, kinase activation, c-Jun NH2-kinase, p38 MAPK, GST fusion protein, co-immunoprecipitation
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cells, Cultured, Enzyme Activation, Cricetinae, Isoenzymes, Molecular Sequence Data, Structure-Activity Relationship, Sequence Alignment, Conserved Sequence, Protein Serine-Threonine Kinases, Sequence Homology, Amino Acid, Calcium-Calmodulin-Dependent Protein Kinases, COS Cells, Ribosomal Protein S6 Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review